• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cornea >Consecutive appearance of corneal subepithelial infiltrates after intravitreous bevacizumab injections.
【24h】

Consecutive appearance of corneal subepithelial infiltrates after intravitreous bevacizumab injections.

机译：玻璃体内注射贝伐单抗注射后连续出现角膜上皮下浸润。

获取原文
获取原文并翻译 | 示例
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

PURPOSE: To report a case of corneal subepithelial infiltrates appearing after intravitreous bevacizumab injections. METHODS: A review of the patient's history and clinical examination findings in a patient who had epidemic keratoconjunctivitis more then 20 years before treatment with bevacizumab for age-related macular degeneration. RESULTS: After the third and fourth bevacizumab injections, the patient presented with unilateral corneal subepithelial infiltrates. The infiltrates were accompanied by mild anterior chamber reaction and resolved with topical steroid treatment. CONCLUSIONS: Treatment with intravitreous bevacizumab may precipitate an immune response leading to the appearance of corneal subepithelial infiltrates.
机译：目的：报告玻璃体内注射贝伐单抗注射后出现角膜上皮下浸润的病例。方法：回顾了在使用贝伐单抗治疗与年龄相关的黄斑变性之前20年以上患有流行性角膜结膜炎的患者的病史和临​​床检查结果。结果：在第三次和第四次贝伐单抗注射后，患者出现单侧角膜上皮下浸润。浸润伴有轻度前房反应，可通过局部类固醇治疗解决。结论：玻璃体内贝伐单抗治疗可能引起免疫反应，导致角膜上皮下浸润的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号